Antibiotic resistance of Mycobacterium tuberculosis complex in Africa : a systematic review of current reports of molecular epidemiology, mechanisms and diagnostics

dc.contributor.authorOsei Sekyere, John
dc.contributor.authorReta, Melese Abate
dc.contributor.authorManingi, Nontuthuko Excellent
dc.contributor.authorFourie, Petrus Bernardus
dc.contributor.emailu18392467@tuks.co.zaen_ZA
dc.date.accessioned2020-02-25T12:17:19Z
dc.date.issued2019-12
dc.descriptionFigure S1: Frequency of M. tuberculosis Lineages/sub-lineages in Africa, January 2007-December 2018: Frequency of Indo-oceanic lineage/sub-lineages (A); Beijing sublineage (B); CAS-sublineage (C), Euro-American lineage/sub-lineages (D); M. africanum West Africa I & II (E); M. tuberculosis Eth lineage 7 and sub-lineages (F); and proportion of each M. tuberculosis lineage in Africa (G).en_ZA
dc.descriptionTable S1: Distribution of M. tuberculosis complex strains, specimen source/s, genotyping method/s, molecular anti-TB drug resistance rate and resistance mechanisms in M. tb across African countries, January 2007 to December 2018en_ZA
dc.descriptionTable S2: Resistance mechanisms, molecular diagnosis method/s used, frequency and proportion of gene mutation per total resistant M. tuberculosis complex isolates across African countries, January 2007- December 2018en_ZA
dc.descriptionTable S3: Molecular antibiotics resistance rates and resistance mechanisms in M. tuberculosis complex across African countries, January 2007-December 2018.en_ZA
dc.descriptionTable S4: Frequency of gene mutation(s) and specific amino acid/nucleotide changes conferring antitubercular drug resistances across African countries January 2007- December 2018en_ZA
dc.descriptionTable S5: Distribution of specimen source/s, phenotypic DST method/s used, total number of isolates, and phenotypic antibiotics monoresistance rate, MDR and XDR rate of M. tb complex across African countries, January 2007- December 2018en_ZA
dc.descriptionTable S6: Distribution of genotypes/lineages/sub-lineages, frequency and patterns of antibiotics resistance-conferring mutations across African countries, January 2007- December 2018en_ZA
dc.descriptionSupplementary dataset 1: Metadata of M. tuberculosis isolates included in phylogenomic analyses.en_ZA
dc.descriptionSupplementary dataset 2: Country-by-country frequency of lineage and sub-lineage of M. tuberculosis in Africa: January 2007-December 2018en_ZA
dc.description.abstractBACKGROUND : Tuberculosis (TB) remains a main global public health problem. However, a systematic review of TB resistance epidemiology in Africa is wanting. METHODS : A comprehensive systematic search of PubMed, Web of Science and ScienceDirect for English research articles reporting on the molecular epidemiology of Mycobacterium tuberculosis complex resistance in Africa from January 2007 to December 2018 was undertaken. RESULTS AND CONCLUSION : Qualitative and quantitative synthesis were, respectively, undertaken with 232 and 186 included articles, representing 32 countries. TB monoresistance rate was highest for isoniazid (59%) and rifampicin (27%), particularly in Zimbabwe (100%), Swaziland (100%), and Sudan (67.9%) whilst multidrug resistance (MDR) rate was substantial in Zimbabwe (100%), Sudan (34.6%), Ivory Coast (24.5%) and Ethiopia (23.9%). Resistance-conferring mutations were commonly found in katG (n = 3694), rpoB (n = 3591), rrs (n = 1272), inhA (n = 1065), pncA (n = 1063) and embB (n = 705) in almost all included countries: S315G/I/N/R/T, V473D/F/G/I, Q471H/Q/R/Y, S303C/L etc. in katG; S531A/F/S/G, H526A/C/D/G, D516A/E/G etc. in rpoB; A1401G, A513C etc. in rrs; -15C→T, -17G→A/T, -16A→G etc. in inhA; Ins456C, Ins 172 G, L172P, C14R, Ins515G etc. in pncA. Commonest lineages and families such as T (n = 8139), LAM (n = 5243), Beijing (n = 5471), Cameroon (n = 3315), CAS (n = 2021), H (n = 1773) etc., with the exception of T, were not fairly distributed; Beijing, Cameroon and CAS were prevalent in South Africa (n = 4964), Ghana (n = 2306), and Ethiopia/Tanzania (n = 799/635), respectively. Resistance mutations were not lineage-specific and sputum (96.2%) were mainly used for diagnosing TB resistance using the LPA (38.5%), GeneXpert (17.2%), whole-genome sequencing (12.3%) and PCR/amplicon sequencing (9%/23%). Intercountry spread of strains was limited while intra-country dissemination was common. TB resistance and its diagnosis remain a major threat in Africa, necessitating urgent action to contain this global menace.en_ZA
dc.description.departmentMedical Microbiologyen_ZA
dc.description.embargo2020-12-01
dc.description.librarianhj2020en_ZA
dc.description.urihttp://www.elsevierhealth.com/journals/jinfen_ZA
dc.identifier.citationOsei Sekyere, J., Reta, M.A., Maningi, N.E. et al. 2019, 'Antibiotic resistance of Mycobacterium tuberculosis complex in Africa : a systematic review of current reports of molecular epidemiology, mechanisms and diagnostics', Journal of Infection, vol. 79, no. 6, pp. 550-571.en_ZA
dc.identifier.issn0163-4453 (print)
dc.identifier.issn1532-2742 (online)
dc.identifier.other10.1016/j.jinf.2019.10.006
dc.identifier.urihttp://hdl.handle.net/2263/73549
dc.language.isoenen_ZA
dc.publisherElsevieren_ZA
dc.rights© 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Notice : this is the author’s version of a work that was accepted for publication in Journal of Infection. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Journal of Infection, vol. 79, no. 6, pp. 550-571, 2019. doi : 10.1016/j.jinf.2019.10.006.en_ZA
dc.subjectMolecular epidemiologyen_ZA
dc.subjectAntibiotic resistanceen_ZA
dc.subjectAntitubercular drugsen_ZA
dc.subjectMycobacterium tuberculosis (MTB)en_ZA
dc.subjectTuberculosis (TB)en_ZA
dc.subjectAfricaen_ZA
dc.titleAntibiotic resistance of Mycobacterium tuberculosis complex in Africa : a systematic review of current reports of molecular epidemiology, mechanisms and diagnosticsen_ZA
dc.typePostprint Articleen_ZA

Files

Original bundle

Now showing 1 - 5 of 22
Loading...
Thumbnail Image
Name:
OseiSekyere_Antibiotic_2019.pdf
Size:
1.27 MB
Format:
Adobe Portable Document Format
Description:
Postprint Article
Loading...
Thumbnail Image
Name:
OseiSekyere_AntibioticFigS1_2019.pdf
Size:
273.84 KB
Format:
Adobe Portable Document Format
Description:
Figure S1
Loading...
Thumbnail Image
Name:
OseiSekyere_AntibioticTabS1_2019.xlsx
Size:
53.53 KB
Format:
Microsoft Excel XML
Description:
Table S1
Loading...
Thumbnail Image
Name:
OseiSekyere_AntibioticTabS2_2019.xlsx
Size:
40.02 KB
Format:
Microsoft Excel XML
Description:
Table S2
Loading...
Thumbnail Image
Name:
OseiSekyere_AntibioticTabS3_2019.xlsx
Size:
37.46 KB
Format:
Microsoft Excel XML
Description:
Table S3

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: